CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	12 Months Ended
	Jan. 31, 2023	Jan. 31, 2022	Jan. 31, 2021
Cash flows from operating activities:
Net income/(loss)	$ 97,023	$ 92,559	$ (111,194)
Adjustments to reconcile net income/(loss) to net cash provided by operating activities:
Impairment of goodwill and intangible assets	0	0	155,919
Non-cash corporate initiatives	0	(926)	3,722
Gain on sale of a non-operating asset	0	0	(1,317)
Depreciation and amortization	10,809	12,463	14,112
Transactional gains	(18)	(808)	(836)
Provision for inventories and accounts receivable	4,091	4,795	3,786
Deferred income taxes	(712)	(208)	(18,292)
Stock-based compensation	5,726	4,952	5,089
Other	453	561	126
Changes in assets and liabilities:
Trade receivables	(3,445)	(18,550)	2,424
Inventories	(28,899)	(15,436)	21,596
Other current assets	(6,427)	2,054	2,261
Income taxes receivable	6,797	17,089	(21,037)
Accounts payable	(13,740)	18,269	(7,811)
Accrued liabilities	(1,127)	1,368	4,480
Accrued payroll and benefits	(7,705)	7,263	11,344
Income taxes payable	(4,104)	1,430	2,142
Other non-current assets	(4,561)	3,258	1,323
Other non-current liabilities	180	681	573
Net cash provided by operating activities	54,341	130,814	68,410
Cash flows from investing activities:
Capital expenditures	(7,085)	(5,656)	(3,018)
Long-term investments	(3,263)	(1,967)	0
Proceeds from sale of a non-operating asset	0	0	1,317
Trademarks and other intangibles	(202)	(291)	(164)
Net cash used in investing activities	(10,550)	(7,914)	(1,865)
Cash flows from financing activities:
Repayments of bank borrowings	0	(21,140)	(64,465)
Proceeds from bank borrowings	0	0	30,879
Dividends paid	(31,363)	(21,973)	0
Stock repurchase	(31,413)	(22,599)	0
Purchase of incremental ownership of joint venture	(1,886)	0	0
Distribution of noncontrolling interest earnings	(1,056)	(1,230)	0
Contributions from noncontrolling interest	0	298	0
Stock awards and options exercised and other changes	489	324	(497)
Debt issuance cost	(85)	(294)	(300)
Net cash used in financing activities	(65,314)	(66,614)	(34,383)
Effect of exchange rate changes on cash, cash equivalents and restricted cash	(4,014)	(2,993)	5,823
Net (decrease)/increase in cash, cash equivalents and restricted cash	(25,537)	53,293	37,985
Cash, cash equivalents and restricted cash at beginning of year	277,716	224,423	186,438
Cash, cash equivalents and restricted cash at end of year	252,179	277,716	224,423
Non-cash financing activities:
Dividends declared but not paid	0	0	2,320
Reconciliation of cash, cash equivalents and restricted cash:
Cash and cash equivalents	251,584	277,128	223,811
Restricted cash included in other non-current assets	595	588	612
Cash, cash equivalents, and restricted cash	$ 252,179	$ 277,716	$ 224,423